|
|
|
|
Vol. 19, Issue 4, 1378-1390, April 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




Departments of *Cancer Biology and ¶Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107;
Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC 20057;
Spanish Cancer Research Center (CNIO), E-28029 Madrid, Spain; and ||Graduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma, Nara 630-0101, Japan
Submitted August 3, 2007;
Revised November 28, 2007;
Accepted January 10, 2008
Monitoring Editor: John Cleveland
The spread of metastatic tumors to different organs is associated with poor prognosis. The metastatic process requires migration and cellular invasion. The protooncogene c-jun encodes the founding member of the activator protein-1 family and is required for cellular proliferation and DNA synthesis in response to oncogenic signals and plays an essential role in chemical carcinogenesis. The role of c-Jun in cellular invasion remains to be defined. Genetic deletion of c-Jun in transgenic mice is embryonic lethal; therefore, transgenic mice encoding a c-Jun gene flanked by LoxP sites (c-junf/f) were used. c-jun gene deletion reduced c-Src expression, hyperactivated ROCK II signaling, and reduced cellular polarity, migration, and invasiveness. c-Jun increased c-Src mRNA abundance and c-Src promoter activity involving an AP-1 site in the c-Src promoter. Transduction of c-jun–/– cells with either c-Jun or c-Src retroviral expression systems restored the defective cellular migration of c-jun–/– cells. As c-Src is a critical component of pathways regulating proliferation, survival, and metastasis, the induction of c-Src abundance, by c-Jun, provides a novel mechanism of cooperative signaling in cellular invasion.
These authors contributed equally to this work.
Address correspondence to: Richard G. Pestell (Richard.Pestell{at}jefferson.edu)
Abbreviations used: AP-1, activator protein 1; Cas, Crk-associated substrate; IRM, interferential reflection microscopy; JNK, c-Jun kinase; LIMK, LIM kinase; MLCK, myosin light-chain kinase; ZRP-1, zyxin-related protein 1.